United States
|
Description
Rosetta Genomics is the first commercial entity to focus on the emerging field of microRNA. The company is a leader in medical research and product development based on microRNA. Using our own proprietary bioinformatic technologies, researchers at Rosetta Genomics have identified the majority of human microRNA of which we are aware. From this unparalleled intellectual property platform, Rosetta is actively advancing multiple internal programs in microRNA diagnostic and therapeutic product development. We are also establishing licensing agreements and collaborative relationships with leading companies and research institutions working to develop microRNA-based products.
Company Profile
Rosetta Genomics is an international leader in diagnostic and therapeutic product development and medical research involving micro-ribonucleic acid, commonly known as microRNA. Rosetta has developed an extensive integrated platform in microRNA research and data that brings together the most advanced findings and capabilities in genomics, bioinformatics and biotechnology. As a result, the company is recognized by leaders in the pharmaceutical and biotechnology industries and in academia as an important resource in the rapidly growing area of microRNA product development.
Originally believed to be components of nonfunctioning “junk DNA”, microRNAs are now known to play a critical role in essential...
| Popularity: |
 |
HIT: 213 | Visit: 17 |
| URL: |
http://www.rosettagenomics.com |
Update URL | Report Broken Link |
| Posted: |
04 July, 2007 06:46 |
| Site Title: |
Leading The MicroRNA Revolution |
| Site Desc: |
Rosetta Genomics is the first commercial entity to focus on the emerging field of microRNA. The company is a leader in medical research and product development based on microRNA. Using our own proprietary bioinformatic technologies, researchers at Rosetta Genomics have identified the majority of human microRNA of which we are aware. From this unparalleled intellectual property platform, Rosetta is actively advancing multiple internal programs in microRNA diagnostic and therapeutic product development. We are also establishing licensing agreements and collaborative relationships with leading companies and research institutions working to develop microRNA-based products. |
| Category: |
BIOMEDICAL / Tissue Engineering |
| Specialized in: |
Diagnostics
- Genomics
- Mir
- Rna
|
| Products: |
Breast cancer, Cancer of Unknown Primary, Colorectal cancer, Infectioous Deseases, Liver cancer, Lung cancer, MicroRNA-Based Cancer Diagnostic Products, MicroRNAs and Therapeutic Products, Prostate cancer
|
 |
| Picture Gallery: |
|
|
| Related sites: |
Bruker BioSpin, BioForce Nanosciences : Home, Laser Measurement, Laser power meter, laser energy meter, laser beam profiler, Infrared optics for IR night vision, thermal imaging and FLIR, CO2 laser Optics, CO2 replacement optics for industrial high power lasers by Ophir Optronics, Oceana Sensor Technologies
|
|
| Related press releases: |
THEMIS Will Judge What Causes Highly Dynamic Aurora, Biochip Allows Genes To Express Themselves, Biocompatible magnetic nanoparticles : Developed By IMEC, Developed the survival and growth of adult stem cells : MIT, Scientists invent real-life 'tricorder' for chemical analysis, Abbott today announced plans to initiate the world’s first drug-eluting stent clinical trial solely in women, In the Public Interest: Nine Points to Consider in Licensing University Technology, If the intestine cancer is early recognized, a healing is possible, Ninety per cent of deaths from colorectal cancer could be avoided,, New XR-4 Camera for Medical and Scientific X-Ray Applications, ‘grow’ bone : Bath Scientists, A new approach to anti-angiogenesis therapy., Virtual worlds are no longer “just games.”, Impac introduces the PowerPath Advanced Materials Processing (AMP) module, Graphite nanofiber : New hope for Mars Mission, Kiessling's group modified an agent known to bind tightly to integrin and tethered it to alpha-Gal, A major aim of developing cancer preventive drugs., Web technology affecting health care, terrorism, defense, financial services, Today’s and Tomorrow’s Commercial Technology : UCR Conference, $50 million gift toward construction of a new building for cardiovascular research and clinical treatment, A microelectromechanical system has invented which can perform cellular experiments that were previously impossible., Agilent to acquire Stratagene Corp. the developer, manufacturer and marketer of specialized life science research and diagnostic products, Toshiba America Medical Systems, Inc. (TAMS) announced today that the nation’s largest outpatient imaging practice, Steinberg Diagnostic Medical Imaging (SDMI) in Las Vegas, is the first to install the new Aplio™ XG ultrasound system, Stone edge/polish machine with one spindle head : Eight times better then previous, Linac Coherent Light Source (LCLS), the world’s first X-ray free-electron laser.
|
|
